![Karl Hsu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Karl Hsu worked as Senior Vice President-Clinical Development at Acrivon Therapeutics, Inc. from 2023 to 2024.
Previously, Dr. Hsu was SVP-Clinical Research & Early Development at Zai Lab Ltd.
Eerdere bekende functies van Karl Hsu
| Bedrijven | Functie | Einde |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 02-01-2024 |
| ZAI LAB LIMITED | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Kies MarketScreener 
